TAVST-01

N/A

Report date: 2026/04/24 20:01:59

Base Information

Drug NameTAVST-01

Drug Alias NameTAVST-01TAVST01

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionAnti-CD276Serpins inhibitors

TargetsCD276 antigenSerpins

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySingapore

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaN/A

Originator CompaniesTikva Allocell Pte Ltd

China Registration ClassN/A

Develop Information

Active CompaniesTikva Allocell Pte Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A